CAH
CARDINAL HEALTH INC
NYSE: CAH · Dublin, OH · Healthcare
$249.57-6.07 (-2.37%)Closed
Market Cap$58.04B
Cash$4.86Bmost recent
Runwayprofitable
P/E (TTM)34.5EPS $7.23
52-Wk Range$160.37 – $257.55
Avg Volume2.1M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$249.57+127.8%
Pipeline

Drug candidates sponsored by CARDINAL HEALTH · ClinicalTrials.gov

3 drugs · 4 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 2Lymphoseek
Anal Cancer
Withdrawn
2017-08past
1
Phase 2Tc99m tilmanocept
Uterine Cervical Neoplasms+2 more
Completed
2019-03-06past
2
N/AUnnamed
Hemodynamics
Unknown
2023-10past
1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for CAH. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.